SeaStar Medical Holding Corp
Research SeaStar Medical Holding Corp (ICU) on Bullrun: market cap USD 14.19M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerICU
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 14.19M
- Financial periodFY2025
- RevenueUSD 1.23M
- Revenue growth814.1%
- Net income-USD 12.15M
- Gross margin95.7%
Valuation Snapshot
latest market cap is USD 14.19M.
About SeaStar Medical Holding Corp
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis.
Frequently asked questions
What is SeaStar Medical Holding Corp's market cap?
SeaStar Medical Holding Corp's market capitalization is USD 14.19M.
What does SeaStar Medical Holding Corp do?
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States.